9 November 2020

FTSE100 rockets as investors see light at the end of the lockdown tunnel

Andrew Boyle, CEO of LGB & Co., commented in a ProActive Investors piece on the Pfizer vaccine announcement. 
 

"The challenges of manufacturing and distributing sufficient quantities of a vaccine are substantial. In the meantime, the virus will evolve."

To read the full piece, click here.

Recent Articles

26 July 2021

PerkinElmer UK completes acquisition of Immunodiagnostics Systems Holdings plc

On 13 July, the AIM quotation of Immunodiagnostics Systems Holdings plc ("IDS") was cancelled following its acquisition by PerkinElmer UK at a price of 382p per share. Read more

News & Insights

20 July 2021

Market Commentary - Q2 2021

Q2 2021 Market Commentary, by Ivan Sedgwick

Read more

News & Insights

7 July 2021

Watch: The AIM market & how to invest in it

We were pleased to host our latest event, "The AIM Market and How to Invest in it", held on Wednesday 7 July at 11 am.

Read more

News & Insights